Vaxcyte (PCVX) 即将公布肺炎球菌疫苗三期数据，市场定价反映增长预期
· gurufocus.com
2026年9月6日，Vaxcyte Inc (纳斯达克: PCVX) 宣布将公布其关键性三期临床试验中肺炎球菌候选疫苗的顶线结果
On September 06, 2026, Vaxcyte Inc (NASDAQ: PCVX) announced it will release topline results from its pivotal Phase 3 trial of the pneumococcal vaccine candidate...